This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raderschall, E. Articles by Haaf, T. Search for Related Content PubMed PubMed Citation Articles by Raderschall, E. Articles by Haaf, T.

Elevated Levels of Rad51 Recombination Protein in Tumor Cells¹

Max Planck Institute of Molecular Genetics, 14195 Berlin, Germany

Rad51 is the key enzyme for homologous recombination, an evolutionarily conserved mechanism for the repair of DNA damage and the generation of genetic diversity. Given the observation that many tumors become resistant to radiation therapy and DNA-damaging chemotherapeutics and also that tumor cell populations can acquire a high number of genetic alterations and then expand clonally, dysfunction of the mammalian Rad51 recombinase could play a major role in the multistep process of tumorigenesis. The data we present provide further strong support for this hypothesis. Using anti-Rad51 immunofluorescence staining, widely different tumor cell lines displayed increased numbers of nuclei with focally concentrated Rad51 protein compared with nonmalignant control cell lines. These nuclear foci are thought to represent a repairosome-type assembly of Rad51 and other proteins required for recombinational DNA repair. By Western blot analyses, the net amount of Rad51 protein was increased 2–7-fold in all tested tumor cell lines. Inhibition of de novo protein synthesis by cycloheximide treatment showed a similar half-life of Rad51 protein in normal and tumor cells. Fluorescence in situ hybridization experiments did not detect Rad51 gene amplifications in tumors. Because Northern blot analysis demonstrated highly elevated Rad51 mRNA levels, we conclude that the increases in Rad51 protein and nuclear foci formation in tumor cells are the result of transcriptional up-regulation.

This article has been cited by other articles:

				O. S. Gildemeister, J. M. Sage, and K. L. Knight Cellular Redistribution of Rad51 in Response to DNA Damage: NOVEL ROLE FOR Rad51C J. Biol. Chem., November 13, 2009; 284(46): 31945 - 31952. [Abstract] [Full Text] [PDF]

				X. Liu, E. K. Han, M. Anderson, Y. Shi, D. Semizarov, G. Wang, T. McGonigal, L. Roberts, L. Lasko, J. Palma, et al. Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways Mol. Cancer Res., October 1, 2009; 7(10): 1686 - 1692. [Abstract] [Full Text] [PDF]

				T. Qin, J. Jelinek, J. Si, J. Shu, and J.-P. J. Issa Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines Blood, January 15, 2009; 113(3): 659 - 667. [Abstract] [Full Text] [PDF]

				C. M. Hine, A. Seluanov, and V. Gorbunova Use of the Rad51 promoter for targeted anti-cancer therapy PNAS, December 30, 2008; 105(52): 20810 - 20815. [Abstract] [Full Text] [PDF]

				J.-C. Ko, J.-H. Hong, L.-H. Wang, C.-M. Cheng, S.-C. Ciou, S.-T. Lin, M.-Y. Jheng, and Y.-W. Lin Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells Mol. Cancer Ther., November 1, 2008; 7(11): 3632 - 3641. [Abstract] [Full Text] [PDF]

				I. Plo, M. Nakatake, L. Malivert, J.-P. de Villartay, S. Giraudier, J.-L. Villeval, L. Wiesmuller, and W. Vainchenker JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders Blood, August 15, 2008; 112(4): 1402 - 1412. [Abstract] [Full Text] [PDF]

				J.-Y. Park, H.-W. Yoo, B.-R. Kim, R. Park, S.-Y. Choi, and Y. Kim Identification of a novel human Rad51 variant that promotes DNA strand exchange Nucleic Acids Res., June 1, 2008; 36(10): 3226 - 3234. [Abstract] [Full Text] [PDF]

				G. Ambrosini, S. L. Seelman, L.-X. Qin, and G. K. Schwartz The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates the Effects of Topoisomerase I Poisons by Suppressing Rad51 Expression in a p53-Dependent Manner Cancer Res., April 1, 2008; 68(7): 2312 - 2320. [Abstract] [Full Text] [PDF]

				S. Adimoolam, M. Sirisawad, J. Chen, P. Thiemann, J. M. Ford, and J. J. Buggy HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination PNAS, December 4, 2007; 104(49): 19482 - 19487. [Abstract] [Full Text] [PDF]

				S. C. Short, C. Martindale, S. Bourne, G. Brand, M. Woodcock, and P. Johnston DNA repair after irradiation in glioma cells and normal human astrocytes Neuro-oncol, October 1, 2007; 9(4): 404 - 411. [Abstract] [Full Text] [PDF]

				R. Francis and C. Richardson Multipotent hematopoietic cells susceptible to alternative double-strand break repair pathways that promote genome rearrangements Genes & Dev., May 1, 2007; 21(9): 1064 - 1074. [Abstract] [Full Text] [PDF]

				J. Lu, L.-E Wang, P. Xiong, E. M. Sturgis, M. R. Spitz, and Q. Wei 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant Carcinogenesis, May 1, 2007; 28(5): 988 - 994. [Abstract] [Full Text] [PDF]

				J. A.F. Hannay, J. Liu, Q.-S. Zhu, S. V. Bolshakov, L. Li, P. W.T. Pisters, A. J.F. Lazar, D. Yu, R. E. Pollock, and D. Lev Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation Mol. Cancer Ther., May 1, 2007; 6(5): 1650 - 1660. [Abstract] [Full Text] [PDF]

				M. H. Luo, K. Rosenke, K. Czornak, and E. A. Fortunato Human Cytomegalovirus Disrupts both Ataxia Telangiectasia Mutated Protein (ATM)- and ATM-Rad3-Related Kinase-Mediated DNA Damage Responses during Lytic Infection J. Virol., February 15, 2007; 81(4): 1934 - 1950. [Abstract] [Full Text] [PDF]

				S. Vijayakumar, D. C. Hall, X. T. Reveles, D. A. Troyer, I. M. Thompson, D. Garcia, R. Xiang, R. J. Leach, T. L. Johnson-Pais, and S. L. Naylor Detection of Recurrent Copy Number Loss at Yp11.2 Involving TSPY Gene Cluster in Prostate Cancer Using Array-Based Comparative Genomic Hybridization. Cancer Res., April 15, 2006; 66(8): 4055 - 4064. [Abstract] [Full Text] [PDF]

				P. Chinnaiyan, S. Huang, G. Vallabhaneni, E. Armstrong, S. Varambally, S. A. Tomlins, A. M. Chinnaiyan, and P. M. Harari Mechanisms of Enhanced Radiation Response following Epidermal Growth Factor Receptor Signaling Inhibition by Erlotinib (Tarceva) Cancer Res., April 15, 2005; 65(8): 3328 - 3335. [Abstract] [Full Text] [PDF]

				J. Libura, D. J. Slater, C. A. Felix, and C. Richardson Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion Blood, March 1, 2005; 105(5): 2124 - 2131. [Abstract] [Full Text] [PDF]

				R. Fan, T. S. Kumaravel, F. Jalali, P. Marrano, J. A. Squire, and R. G. Bristow Defective DNA Strand Break Repair after DNA Damage in Prostate Cancer Cells: Implications for Genetic Instability and Prostate Cancer Progression Cancer Res., December 1, 2004; 64(23): 8526 - 8533. [Abstract] [Full Text] [PDF]

				R. Natrajan, J. Louhelainen, S. Williams, J. Laye, and M. A. Knowles High-Resolution Deletion Mapping of 15q13.2-q21.1 in Transitional Cell Carcinoma of the Bladder Cancer Res., November 15, 2003; 63(22): 7657 - 7662. [Abstract] [Full Text] [PDF]

				J. S. Russell, K. Brady, W. E. Burgan, M. A. Cerra, K. A. Oswald, K. Camphausen, and P. J. Tofilon Gleevec-Mediated Inhibition of Rad51 Expression and Enhancement of Tumor Cell Radiosensitivity Cancer Res., November 1, 2003; 63(21): 7377 - 7383. [Abstract] [Full Text] [PDF]

				S. P. Linke, S. Sengupta, N. Khabie, B. A. Jeffries, S. Buchhop, S. Miska, W. Henning, R. Pedeux, X. W. Wang, L. J. Hofseth, et al. p53 Interacts with hRAD51 and hRAD54, and Directly Modulates Homologous Recombination Cancer Res., May 15, 2003; 63(10): 2596 - 2605. [Abstract] [Full Text] [PDF]